Hexagon Nutrition Board Approves Q1 FY27 Results, Declares Dividend, Appoints Director
Hexagon Nutrition approved Q1 FY27 results and recommended a final dividend of ₹0.30 per share. The AGM is on Sept 22, 2026. Key management remuneration revised, Mr. Raghunath Sawant appointed as Additional Executive Director.
The declaration of dividend, appointment of a new director, and approval of financial results are significant events for shareholders and stakeholders, impacting governance and shareholder returns.
The announcement details routine financial results, dividend declaration, and board appointments, which are standard corporate actions. While positive events like dividend are present, there are no significant positive or negative financial performance indicators highlighted in the summary.
Hexagon Nutrition Limited's Board of Directors, in a meeting held on August 12, 2026, approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board also recommended a final dividend of ₹0.30 per equity share for the financial year ended March 31, 2026.
The 33rd Annual General Meeting (AGM) is scheduled for September 22, 2026, commencing at 11:30 a.m. via Video Conferencing. The book closure for the AGM will be from September 16 to September 22, 2026. The record date for determining eligibility for the final dividend is fixed as September 15, 2026.
Further, the Board approved revisions in the annual remuneration for Chairman and Executive Director Mr. Arun Purushottam Kelkar, Managing Director Mr. Vikram Arun Kelkar, and Joint Managing Director Dr. Nikhil Arun Kelkar, subject to member approval at the AGM. The reappointment of Mr. Arun Purushottam Kelkar as Chairman & Director was also recommended, pending member approval.
Mr. Raghunath Sawant has been appointed as an Additional Executive Director effective August 12, 2026. The Articles of Association of the Company will be altered, subject to member approval. Additionally, the IPO Committee has been dissolved following the successful completion of the IPO. The trading window will open 48 hours after the declaration of financial results for the quarter ended June 30, 2026.
What to do with a filing like this
Hexagon Nutrition Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Hexagon Nutrition Limited. Read the original for the full detail.